Clofert 100 mg (Clomiphene)

Product Overview

Clofert 100 mg is a prescription medication formulated to support ovulation induction in women experiencing infertility. The product is manufactured by Svizera Maneesh Pharma and is supplied in packs of ten tablets per strip. Each tablet contains 100 mg of clomiphene citrate a well studied agent used in the management of female infertility. The medication is available in multiple pack sizes including thirty tablets sixty tablets and ninety tablets to accommodate varying treatment cycles and clinical needs. This formulation is intended for oral administration and should be stored at room temperature away from moisture and direct sunlight.

What is Clofert 100 mg

Clofert belongs to a class of drugs known as selective estrogen receptor modulators. The active ingredient clomiphene works by stimulating the release of hormones necessary for the development and release of a mature egg. It is indicated for women who do not ovulate regularly or who have unexplained infertility. The drug is not intended for use in men or in children and should only be prescribed after a comprehensive evaluation of reproductive health. Understanding the underlying cause of infertility is essential before initiating therapy with this agent.

Uses and Benefits

The primary use of Clofert 100 mg is to improve the chances of conception in women with ovulatory disorders. Clinical studies have demonstrated that ovulation can be restored in a significant proportion of patients after a short course of treatment. Benefits include more regular menstrual cycles improved endometrial thickness and increased probability of pregnancy when combined with timed intercourse or assisted reproductive techniques. The medication is valued for its oral administration route and relatively low cost compared with more invasive procedures such as in vitro fertilization. Additionally the drug can be used in combination with other supportive therapies under the supervision of a qualified healthcare professional.

How It Works

Clomiphene exerts its effect by binding to estrogen receptors in the hypothalamus which leads to an increase in the secretion of gonadotropin releasing hormone. This in turn stimulates the anterior pituitary to release follicle stimulating hormone and luteinizing hormone. The resulting hormonal surge promotes follicular development and triggers ovulation. The drug’s selective receptor modulation allows it to act as an antagonist in some tissues while acting as an agonist in others which contributes to its favorable safety profile. This mechanism distinguishes Clofert from other ovulation induction agents and provides a predictable response when used according to established protocols.

Dosage Guidelines

Treatment typically begins with a single tablet taken daily for five consecutive days early in the menstrual cycle. The exact day of initiation is often determined by a healthcare professional based on individual cycle length and prior response. If ovulation does not occur the dose may be increased to one hundred milligrams per day in subsequent cycles but should not exceed the recommended maximum without medical supervision. Patients are advised to undergo regular monitoring through ultrasound or hormone assays to assess follicular growth and to adjust timing of intercourse accordingly. It is essential that the medication is prescribed after a thorough evaluation and that follow up visits are scheduled to address any emerging concerns. The duration of therapy is generally limited to several cycles to minimize the risk of ovarian hyperstimulation.

Side Effects

Like all pharmaceutical products Clofert may be associated with adverse reactions. The most frequently reported side effects include hot flashes breast tenderness abdominal discomfort and visual disturbances such as blurred vision. Some users may experience mood changes or mild headaches. Although rare serious complications such as ovarian hyperstimulation syndrome have been documented FDA. If any of these symptoms become severe or persistent medical attention should be sought immediately. Long term use of clomiphene is generally discouraged because of potential impacts on ovarian reserve and endometrial health.

Warnings and Precautions

Clofert is contraindicated in individuals with known hypersensitivity to clomiphene or any of the excipients. The drug should not be used by pregnant or breastfeeding women as it may affect fetal development. Patients with liver disease ovarian cysts or abnormal uterine bleeding should discuss their medical history with a clinician before starting therapy. Concomitant use of other hormonal treatments is generally discouraged unless specifically directed by a healthcare provider. Clinical guidelines from the NIH provide additional context NIH. It is recommended that treatment cycles be limited in number and that a comprehensive assessment of ovarian reserve be performed periodically.

Frequently Asked Questions

Question 1
What is the typical duration of a Clofert treatment cycle

Answer 1
A standard cycle involves five days of daily dosing followed by a waiting period of approximately two weeks before evaluating ovulation and pregnancy outcomes.

Question 2
Can Clofert be used together with other fertility supplements

Answer 2
Combining Clofert with over the counter supplements is not routinely recommended without medical guidance because interactions may alter hormonal balance.

Question 3
Is it safe to continue Clofert if a pregnancy is confirmed

Answer 3
Discontinuation of the medication is advised once pregnancy is confirmed to avoid any unnecessary exposure to the developing fetus.

Question 4
How does Clofert differ from injectable fertility medications

Answer 4
Clofert is an oral agent that stimulates natural hormone production whereas injectable agents deliver exogenous hormones directly which can result in a different risk profile and cost structure.

Question 5
Where can I find more detailed prescribing information

Answer 5
Additional details are available through reputable sources such as the NIH Office of Dietary Supplements the FDA drug label database and MedlinePlus which provide evidence based guidance on clomiphene therapy NIH.

Related Products

• ZyhCG 10000 (HCG 10000iu)
• ZyhCG 5000 (HCG 5000iu)
• ZyhCG 2000 (HCG 2000iu)
• Sifasi Aqua 5000 (HCG (Human Chorionic Gonadotropin))
• Clomiphene 50 mg (Generic)
• Clomiphene 100 mg (Generic)
• Clomiphene 25 mg (Generic)
• Progesterone Vaginal Gel 1.125 g (Generic)
• Fertomid 25 mg (Clomiphene)
• Clofert 50 mg (Clomiphene)
• Clofert 25 mg (Clomiphene)
• Clofert (Clomiphene)